Cabaletta BioPhiladelphia, Pennsylvania, United States
Computational Biologist
0324: Correlative Studies of CABA-201, a Fully Human, Autologous 4-1BB Anti-CD19 CAR T Cell Therapy in Patients with Immune-Mediated Necrotizing Myopathy and Systemic Lupus Erythematosus from the RESET-MyositisTM and RESET-SLETM Clinical Trials
Saturday, November 16, 202410:30 AM – 12:30 PM Eastern Time
No financial relationships with ineligible companies to disclose